{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:15:42Z","timestamp":1781532942507,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014554","name":"Janssen Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000850","name":"National Heart and Lung Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008021","name":"Bristol-Myers Squibb Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010875","name":"Amgen Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["5T32HL007093"],"award-info":[{"award-number":["5T32HL007093"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jgo.2020.04.008","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T16:27:54Z","timestamp":1587140874000},"page":"764-768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma"],"prefix":"10.1016","volume":"11","author":[{"given":"Hira","family":"Mian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakira J.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Pawlyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bringhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Zweegman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia A.M.","family":"Stege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E.","family":"Rosko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"von Lilienfeld-Toal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Wildes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.jgo.2020.04.008_bb0005","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jgo.2020.04.008_bb0010","article-title":"Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China","author":"Zhang","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2020.04.008_bb0015","article-title":"Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up","volume":"30","author":"Wang","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.jgo.2020.04.008_bb0020","article-title":"The COVID-19 pandemic in the US: a clinical update","volume":"6","author":"Omer","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jgo.2020.04.008_bb0025","author":"Coronavirus Resource Center: John Hopkins University and Medicine"},{"issue":"4","key":"10.1016\/j.jgo.2020.04.008_bb0030","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1002\/ajh.23932","article-title":"Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: a study based on the nationwide Danish Myeloma Database","volume":"90","author":"Holmstrom","year":"2015","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.jgo.2020.04.008_bb0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3324\/haematol.2014.107714","article-title":"Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients","volume":"100","author":"Blimark","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jgo.2020.04.008_bb0040","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2019.242958","article-title":"Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age","author":"Engelhardt","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jgo.2020.04.008_bb0045","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jgo.2020.04.008_bb0050","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6915e3","article-title":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 \u2014 COVID-NET, 14 States, March 1\u201330, 2020","author":"Garg","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jgo.2020.04.008_bb0055","series-title":"Characteristics of COVID-19 patients dying in Italy Report based on available data on April 9th, 2020","year":"2020"},{"issue":"7","key":"10.1016\/j.jgo.2020.04.008_bb0060","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1182\/bloodadvances.2020001907","article-title":"First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab","volume":"4","author":"Zhang","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jgo.2020.04.008_bb0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2020.04.008_bb0070","series-title":"Patients with Cancer Appear More Vulnerable to S.-C.-2: A M.-C. Study During the COVID-19 Outbreak (3\/17\/2020)","author":"Dai","year":"2020"},{"issue":"8","key":"10.1016\/j.jgo.2020.04.008_bb0075","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1080\/10428190500472503","article-title":"Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections","volume":"47","author":"Schutt","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1016\/j.jgo.2020.04.008_bb0080","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.12.2000334","article-title":"Rapid assessment of regional SARS-CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands, March 2020","volume":"25","author":"Reusken","year":"2020","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.jgo.2020.04.008_bb0085","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3324\/haematol.2016.145078","article-title":"Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma","volume":"102","author":"Kastritis","year":"2017","journal-title":"Haematologica."},{"issue":"11","key":"10.1016\/j.jgo.2020.04.008_bb0090","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood-2010-09-307645","article-title":"Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients","volume":"117","author":"Gay","year":"2011","journal-title":"Blood."},{"issue":"2","key":"10.1016\/j.jgo.2020.04.008_bb0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41375-019-0595-5","article-title":"The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial","volume":"34","author":"Pawlyn","year":"2020","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.jgo.2020.04.008_bb0100","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1532-5415.2005.53312.x","article-title":"Frailty and its definition: a worthy challenge","volume":"53","author":"Rockwood","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.jgo.2020.04.008_bb0105","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1016\/S2352-3026(18)30220-5","article-title":"A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study","volume":"6","author":"Cook","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jgo.2020.04.008_bb0110","article-title":"Development of a medicare health outcomes survey deficit-accumulation frailty index and its application to older patients with newly diagnosed multiple myeloma","volume":"2","author":"Mian","year":"2018","journal-title":"JCO Clin Cancer Inform"},{"issue":"5","key":"10.1016\/j.jgo.2020.04.008_bb0115","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3324\/haematol.2016.162693","article-title":"A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients","volume":"102","author":"Engelhardt","year":"2017","journal-title":"Haematologica."},{"issue":"13","key":"10.1016\/j.jgo.2020.04.008_bb0120","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report","volume":"125","author":"Palumbo","year":"2015","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.jgo.2020.04.008_bb0125","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood.2019000758","article-title":"Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies","volume":"134","author":"Liu","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jgo.2020.04.008_bb0130","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2522\/ptj.20110053","article-title":"The modified Gait Efficacy Scale: establishing the psychometric properties in older adults","volume":"92","author":"Newell","year":"2012","journal-title":"Phys Ther"},{"key":"10.1016\/j.jgo.2020.04.008_bb0135","author":"Myeloma Patient Safety and the Coronovirus: International Myeloma Foundation"},{"key":"10.1016\/j.jgo.2020.04.008_bb0140","author":"American Society of Transplantation and Cellular Therapy: Reponse to COVID-19"},{"key":"10.1016\/j.jgo.2020.04.008_bb0145","author":"COVID -19 and Multiple Myeloma: Frequently Asked Questions (American Society of Hematology)"},{"issue":"12","key":"10.1016\/j.jgo.2020.04.008_bb0150","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2020.04.008_bb0155","author":"Coronavirus Disease Covid-19: European Society for Blood and Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jgo.2020.04.008_bb0160","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3324\/haematol.2012.075051","article-title":"Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials","volume":"98","author":"Bringhen","year":"2013","journal-title":"Haematologica."},{"issue":"9","key":"10.1016\/j.jgo.2020.04.008_bb0165","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1634\/theoncologist.2017-0592","article-title":"Representation of minorities and elderly patients in multiple myeloma clinical trials","volume":"23","author":"Duma","year":"2018","journal-title":"Oncologist."},{"key":"10.1016\/j.jgo.2020.04.008_bb0170","author":"ASH RC COVID-19 Registry for Hematologic Malignancy"},{"key":"10.1016\/j.jgo.2020.04.008_bb0175","author":"The COVID-19 and Cancer Consortium"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406820301909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406820301909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:51:51Z","timestamp":1761817911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406820301909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1879406820301909"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2020.04.008","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2020.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}